Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis (Q43816241)

27 November 2017

title

Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis (English)

1 reference

27 November 2017

Cuzzocrea S

1

1 reference

27 November 2017

Mazzon E

2

1 reference

27 November 2017

Dugo L

3

1 reference

27 November 2017

Caputi AP

4

1 reference

27 November 2017

Riley DP

5

1 reference

27 November 2017

Salvemini D

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

European Journal of Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

432

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

79-89

1 reference

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Value of indium-111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Rapid neutrophil adhesion to activated endothelium mediated by GMP-140.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Oxidants and free radicals in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Peroxynitrite formation from macrophage-derived nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Expression of vascular adhesion molecules in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Oxygen radicals: mediators of gastrointestinal pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Infliximab for the treatment of fistulas in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Peroxynitrite-induced rat colitis--a new model of colonic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Successful management of Crohn's disease of the ileoanal pouch with infliximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Monocyte stimulation by reactive oxygen species: role of superoxide and intracellular Ca2+.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901427-3

10.1016/S0014-2999(01)01427-3

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference